# Celadon Partners

> Celadon Partners is a VC fund in Hong Kong backing Biotechnology and Medical. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hong Kong, Hong Kong
- Total investments: 4
- Last investment: Mar 2025
- Lead investor: 75%
- Last fund: Nov 2022
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/celadon-partners/about/
- Website: https://www.celadonpartners.com/

Celadon Partners is a private equity manager with a focus on transformative innovations.

## Contacts

5 contacts available for Celadon Partners. Shizune tracks 1 team members at Celadon Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/celadon-partners?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Medical | 1 | 25% |
| Biopharma | 1 | 25% |
| Coworking | 1 | 25% |
| Incubators | 1 | 25% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series A | 1 | 25% |
| Funding Round | 1 | 25% |
| Post-IPO Equity | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 2 | 50% |
| Japan | 1 | 25% |
| United States | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Donald Tang | Founder and Managing Partner | 1 | https://shizune.co/investors/profile/donald-tang-04dc |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| RegCell | RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer . | $8.5M | Seed | Mar 18, 2025 |  |
| Senti Biosciences | Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost. | $47.6M | Post-IPO Equity | Dec 02, 2024 |  |
| NSG BioLabs | NSG BioLabs is a co-working laboratory made specifically to develop revolutionary biotechnology ventures. The company has a global infrastructure that supports new and growing ventures. With large laboratory benches, several tissue culture suites, a list of shared core equipment, and a group of selected tenants and partners in its sites. It is acomplete global life sciences incubation ecosystem.NSG BioLabs was founded on 2019 and is headquartered in Singapore. | $14.5M | Venture - Series Unknown | May 07, 2024 |  |
| GDMC | GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines. | $21M | Series A | Jan 24, 2024 |  |

4 of 4 investments shown.

## Co-investors
- [ClavystBio](https://shizune.co/investors/profile/clavystbio) — VC Fund, 1 deal together
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 1 deal together
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 1 deal together
- [Leaps by Bayer](https://shizune.co/investors/profile/leaps-by-bayer) — VC Fund, 1 deal together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 1 deal together
- [Nantahala Capital Management](https://shizune.co/investors/profile/nantahala-capital-management) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Everywhere Ventures](https://shizune.co/investors/profile/everywhere-ventures) — VC Fund
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Singapore](https://shizune.co/investors/biotechnology-investors-singapore)
- [Biotech Investors in Singapore](https://shizune.co/investors/biotech-investors-singapore)
- [Biotechnology VC Funds in Singapore](https://shizune.co/investors/biotechnology-vc-funds-singapore)
- [Biotech VC Funds in Singapore](https://shizune.co/investors/biotech-vc-funds-singapore)
- [Manufacturing Investors in Singapore](https://shizune.co/investors/manufacturing-investors-singapore)
- [Manufacturing VC Funds in Singapore](https://shizune.co/investors/manufacturing-vc-funds-singapore)

## FAQ

### What does Celadon Partners invest in?

Celadon Partners invests primarily in Biotechnology, Medical and Biopharma startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Celadon Partners?

Public channels for Celadon Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Celadon Partners?

The team at Celadon Partners includes Donald Tang (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co